Business

Thermo Fisher Scientific’s TaqPath COVID-19 Tests can detect the presence of the Omicron variant in SARS-CoV-2 samples

Mumbai (Maharashtra) [India], December 01: Thermo Fisher Scientific, the world leader in serving science, confirmed that its TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit can accurately detect the presence of the new Omicron variant in SARS-CoV-2 samples. The test works on the primer-probe detection method and is not impacted by the emerging B.1.1.529 or Omicron variant.

The World Health Organization (WHO) classified the Omicron variant as a SARS-CoV-2 “variant of concern” with more than 30 mutations in the spike protein alone. This variant has caused renewed restriction across countries and research to examine the variant’s impact on the efficacy of existing vaccines and tests.

The TaqPath COVID-19 assays detect SARS-CoV-2 infections by identifying the presence of three gene targets from the orf1a/b, S, and N regions of the virus. While the S gene target in the test is impacted in the presence of Omicron variant mutations, the orf1a/b and N gene targets in the TaqPath COVID-19 tests have been determined to not be impacted by any of the mutations.

“Thermo Fisher is committed to supporting the world’s pandemic response by developing innovative, adaptive and resilient testing solutions. Our TaqPath Assays are developed with additional built-in checks to ensure that clinicians, researchers and public health officials have access to effective tools to accurately detect mutations as the virus continues to evolve,” said Amit Chopra, managing director India and South Asia, Thermo Fisher Scientific.

The Omicron variant has been found to include the 69-70del mutation of the S gene, first identified as a mutation in the Alpha variant. This mutation causes a dropout of the S-gene target in results from the TaqPath test, which could indicate to clinicians and researchers a possible Omicron variant infection. Confirmation must then be performed by sequencing the sample.

For more information, please visit:

https://www.thermofisher.com/order/catalog/product/A48067

About Thermo Fisher Scientific 

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon. For more information, please visit www.thermofisher.com

Contact: Mihir Deshpande

mihir.deshpande@thermofisher.com

25 Replies to “Thermo Fisher Scientific’s TaqPath COVID-19 Tests can detect the presence of the Omicron variant in SARS-CoV-2 samples

  1. Please let me know if you’re looking for a article author for your blog. You have some really great articles and I believe I would be a good asset. If you ever want to take some of the load off, I’d really like to write some content for your blog in exchange for a link back to mine. Please blast me an e-mail if interested. Kudos!

  2. When I originally commented I clicked the -Notify me when new comments are added- checkbox and now each time a comment is added I get four emails with the same comment. Is there any way you can remove me from that service? Thanks!

  3. What’s Happening i’m new to this, I stumbled upon this I’ve found It absolutely helpful and it has helped me out loads. I hope to contribute & help other users like its aided me. Good job.

  4. Its like you read my mind! You seem to know a lot about this, like you wrote the book in it or something. I think that you can do with a few pics to drive the message home a bit, but instead of that, this is great blog. An excellent read. I will definitely be back.

  5. Undeniably consider that which you said. Your favorite reason appeared to be on the web the easiest factor to keep in mind of. I say to you, I definitely get irked whilst people think about concerns that they plainly don’t understand about. You managed to hit the nail upon the highest and outlined out the entire thing without having side effect , other folks could take a signal. Will likely be again to get more. Thanks

  6. Hey very nice website!! Man .. Beautiful .. Amazing .. I will bookmark your blog and take the feeds also…I’m happy to find a lot of useful info here in the post, we need develop more techniques in this regard, thanks for sharing. . . . . .

  7. What i don’t understood is in fact how you are now not really a lot more smartly-favored than you may be now. You’re so intelligent. You know therefore significantly on the subject of this subject, produced me for my part consider it from a lot of numerous angles. Its like men and women are not fascinated except it is one thing to do with Girl gaga! Your individual stuffs excellent. Always deal with it up!

  8. Hello there! I know this is kinda off topic nevertheless I’d figured I’d ask. Would you be interested in exchanging links or maybe guest writing a blog article or vice-versa? My blog addresses a lot of the same subjects as yours and I believe we could greatly benefit from each other. If you are interested feel free to shoot me an email. I look forward to hearing from you! Wonderful blog by the way!

Leave a Reply

Your email address will not be published.